Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Synthetic Cannabinoids Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The synthetic cannabinoids market has witnessed a rapid expansion in recent years. It is anticipated to increase from $2.2 billion in 2025 to $2.59 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.6%. This historical growth can be linked to various factors such as the constraints of plant-derived cannabinoids, the need for potency control, pharmaceutical research requirements, the rise of pain management therapies, and regulatory approvals in specific areas.
The synthetic cannabinoids market size is expected to experience significant expansion in the coming years. It is projected to increase to $4.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.4%. This growth during the forecast period is attributable to the expansion of medical cannabis, the development of controlled cannabinoid therapeutics, the demand for precision dosing, the scalability of synthetic APIs, and investments in pharmaceutical R&D. Prominent trends for this period include the broadening of pharmaceutical-grade cannabinoids, an increasing use of synthetic cannabinoids in research, a rising need for high-purity formulations, a move towards regulated medical applications, and progress in controlled synthesis techniques.
Get A Free Sample Report With In-Depth Market Insights:
Synthetic Cannabinoids Market Demand Drivers Opening New Revenue Streams
The increasing requirement for treatments for neurological disorders is anticipated to stimulate the future growth of the synthetic cannabinoids market. These conditions involve diseases of the brain, spinal cord, and nerves that disrupt movement, sensation, cognition, or overall functioning. The expanding prevalence of neurological disorders is primarily linked to the aging global population, as conditions such as Alzheimer’s become more common with age due to brain aging and accumulated cellular damage. Synthetic cannabinoids act on cannabinoid receptors in the brain, assisting in the regulation of neurotransmitter activity and potentially easing symptoms related to neurological disorders. For instance, in September 2024, the European Brain Council, a Belgium-based health organization, reported that 7 million people in Europe are currently living with Alzheimer’s disease, a figure expected to double to 14 million by 2030 due to an aging population, establishing it as a significant global public health challenge. Thus, the escalating demand for neurological disorder treatments is propelling the growth of the synthetic cannabinoids market.
Synthetic Cannabinoids Market Segment Analysis Spotlighting Growth Areas
The synthetic cannabinoids market covered in this report is segmented –
1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids
2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals
3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications
4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids
2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids
Synthetic Cannabinoids Market Trends Powering Strategic Industry Growth
Leading companies in the synthetic cannabinoids market are concentrating on producing safer, high-quality products, such as novel psychoactive substances, to diminish health risks and reinforce their market competitiveness. Novel psychoactive substances are laboratory-engineered designer drugs that imitate the effects of traditional illicit substances but incorporate modified chemical structures to avoid detection and regulation. For example, Quest Diagnostics Inc., a US-based healthcare firm, introduced an 88-compound Novel Psychoactive Substance (NPS) Test Panel in December 2023. This panel aims to more accurately identify a broad spectrum of synthetic cannabinoids and other designer drugs. This new mass-spectrometry-based test offers improved detection of evolving synthetic cannabinoids, assisting healthcare providers in understanding patient exposure more clearly and making better treatment decisions. The availability of such advanced testing solutions underscores the increasing requirement for trustworthy monitoring tools as synthetic cannabinoids continue to develop, thereby ensuring heightened safety, transparency, and regulatory adherence within the market.
Synthetic Cannabinoids Market Leading Companies: Who Holds The Strongest Market Presence?
Major companies operating in the synthetic cannabinoids market are Cayman Chemical, Cerilliant Corporation, Restek Corporation, Chiron AS, BayMedica, CB Therapeutics Inc., Skye Bioscience, Zynerba Pharmaceuticals Inc., Botanix Pharmaceuticals, Kannalife Sciences Inc., SciSparc Ltd., Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd., BioVectra, Noramco Inc., Purisys LLC, Lygos Inc., Johnson Matthey, Almac Group, Cambrex Corporation
View The Full Synthetic Cannabinoids Market Report:
Synthetic Cannabinoids Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the synthetic cannabinoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model